Pharmacology

Action Mechanism of Action Reference
INHIBITOR Elongation factor 2 inhibitor FDA PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 4 D015470 FDA
Myelodysplastic Syndromes 1 D009190 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297573
FDA SRS 8ZHS5657EH